Inflammatory Cardiomyopathy Baseline Cohort (SFB/TR19)

Inflammatory Cardiomyopathy Cohort of the SFB/TR19 [Kohorte Entzündliche Kardiomyopathien Des Sonderforschungsbereichs/Transregio 19 (SFB/TR19)]

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02970227

Acronym

SFB/TR19

Enrollment

920

Registered

2016-11-21

Start date

2004-01-31

Completion date

2015-06-30

Last updated

2016-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiomyopathies, Heart Failure

Keywords

heart failure, cardiomyopathies, myocarditis

Brief summary

cohort of cardiomyopathy patients (suspected or validated inflammatory cardiomyopathy) recruited at baseline by the SFB-TR19 project. Standardized protocols used for the assessment of medical history and examinations, laboratory biomarkers, and the collection of various biosamples for biobanking purposes.

Interventions

OTHERObservation

None, observation only

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* suspected inflammatory cardiomyopathy at baseline

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame	Description
Cardiovascular events	1-year follow-ups	Hospitalization (HF based. all-cause), interventions (ICD, pacemaker), myocardial infarction

Secondary

Measure	Time frame	Description
LVEF	1-year follow-ups	Left ventricular ejection fraction at time of follow-up
VO2peak	1-year follow-ups	Exercise capacity by CPET
QOL	1-year follow-ups	Quality of life by questionnaire (Minnesota Living with HF questionnaire)
Mortality	1-year follow-ups	Mortality (HF-related, CVD, all-cause)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026